Viewing Study NCT01496495


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2025-12-26 @ 10:23 PM
Study NCT ID: NCT01496495
Status: COMPLETED
Last Update Posted: 2020-09-09
First Post: 2011-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes
Sponsor: Array Biopharma, now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module